Early research (Phase 1)Study completedNCT00346853What this trial is testingPhase 1 Pilot Study of 4-MP to Treat Stargardt Macular DystrophyWho this might be right forMacular Dystrophy, Corneal University of Utah 10
Testing effectiveness (Phase 2)Looking for participantsNCT06942572What this trial is testingA Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)Who this might be right forStargardt DiseaseStargardt Macular DegenerationStargardt Macular Dystrophy Splice Bio 57
Not applicableStudy completedNCT02410122What this trial is testingThe Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular DystrophyWho this might be right forStargardt Disease Johns Hopkins University 15
Early research (Phase 1)Study completedNCT02230228What this trial is testingPhase 1 Safety Study of ALK-001 in Healthy VolunteersWho this might be right forStargardt DiseaseAge-related Macular DegenerationOther Retinal Dystrophies Alkeus Pharmaceuticals, Inc. 40
Not applicableUnknownNCT04281732What this trial is testingVisual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those With Severely Reduced VisionWho this might be right forLow VisionRetinitis PigmentosaStargardt Disease 1+3 more Queen's University, Belfast 20
Not applicableLooking for participantsNCT06435000What this trial is testingAn Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 GeneWho this might be right forStargardtStargardt's DiseaseStargardt Disease+1 more Splice Bio 75
Testing effectiveness (Phase 2)Study completedNCT04489511What this trial is testingStudy of STG-001 in Subjects With Stargardt DiseaseWho this might be right forStargardt Disease-1 Stargazer Pharmaceuticals, Inc. 10